Atlas Trials

Study Comparing ZG006 With Investigator-Selected Chemotherapy in Participants With Relapsed Small Cell Lung Cancer

Clinical trial NCT07189455 · RECRUITING

Trial details

NCT number
NCT07189455
Sponsor
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Small-cell Lung Cancer
Start date
2025-12-12
Primary completion
2028-10-01
Enrollment
420

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.